Independent fund research. Built on SEC filings.

How we research funds

ETF · Technology Sector · iShares

IBB Holdings: What iShares Biotechnology ETF Owns

Ticker IBB · Since 2001-02-05 · · Holdings as of Sep 30, 2025

Expense ratio
0.44%$44/yr per $10k
5-yr return
+2.5%annualized
1-yr return
+28.0%as of Dec 2025
Net assets
$5.9Ball share classes
Holdings
254

Bottom line

What does IBB hold?

IBB held 254 positions as of Sep 30, 2025. Its largest holding is BlackRock Funds III at 13.18% of the fund, and the top 10 positions add up to 59%. By asset type it is 100% stocks, 13% cash & short-term funds.

Updated Jul 13, 2026

IBB top 25 holdings

#HoldingType% of fundValue
1 BlackRock Funds III
BlackRock Cash Funds: Institutional, SL Agency Shares
Cash & short-term funds 13.18%$783.1M
2 Vertex Pharmaceuticals, Inc. Stocks 7.66%$455.3M
3 Gilead Sciences, Inc. Stocks 7.52%$446.5M
4 Amgen, Inc. Stocks 7.50%$445.8M
5 Regeneron Pharmaceuticals, Inc. Stocks 5.70%$338.6M
6 Alnylam Pharmaceuticals, Inc. Stocks 5.68%$337.5M
7 IQVIA Holdings, Inc. Stocks 3.18%$188.7M
8 Argenx SE Stocks 3.15%$187.1M
9 Insmed, Inc. Stocks 2.95%$175.5M
10 Mettler-Toledo International, Inc. Stocks 2.49%$148.0M
11 Natera, Inc. Stocks 2.11%$125.6M
12 BeOne Medicines Ltd. Stocks 2.11%$125.2M
13 Biogen, Inc. Stocks 2.03%$120.9M
14 United Therapeutics Corp. Stocks 1.82%$108.1M
15 Waters Corp. Stocks 1.77%$105.0M
16 Incyte Corp. Stocks 1.62%$96.5M
17 Illumina, Inc. Stocks 1.41%$83.7M
18 Genmab A/S Stocks 1.38%$81.9M
19 Neurocrine Biosciences, Inc. Stocks 1.34%$79.9M
20 Medpace Holdings, Inc. Stocks 1.16%$68.8M
21 Exelixis, Inc. Stocks 1.07%$63.5M
22 Ionis Pharmaceuticals, Inc. Stocks 1.03%$61.0M
23 BioMarin Pharmaceutical, Inc. Stocks 1.02%$60.4M
24 Madrigal Pharmaceuticals, Inc. Stocks 0.92%$54.5M
25 Moderna, Inc. Stocks 0.88%$52.3M

Source: SEC Form N-PORT, period ended Sep 30, 2025, filed Jul 13, 2026

Asset mix

Stocks99.8%
Cash & short-term funds13.4%

Country exposure

BM0.7%
CA0.6%
CH2.7%
DE0.7%
DK2.2%
GB1.0%
IE0.5%
JE0.1%
KY0.9%
NL4.3%